Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study
暂无分享,去创建一个
J. Dwyer | C. Nordstrom | C. N. Merz | K. Dwyer | Yuching Yang | A. Shircore | P. Mehta | P. Sun | M. Paul-Labrador | M. Agarwal
[1] T. Mäkikallio,et al. Low β-carotene concentrations increase the risk of cardiovascular disease mortality among Finnish men with risk factors. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] R. Keogh,et al. Vitamin C intake from diary recordings and risk of breast cancer in the UK Dietary Cohort Consortium , 2012, European Journal of Clinical Nutrition.
[3] J. Manson,et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.
[4] J. M. May,et al. Inflammation in the vascular bed: importance of vitamin C. , 2008, Pharmacology & therapeutics.
[5] J. Curb,et al. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. , 2008, The American journal of cardiology.
[6] J. Manson,et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.
[7] Honglin Song,et al. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[8] H. Schellhorn,et al. New developments and novel therapeutic perspectives for vitamin C. , 2007, The Journal of nutrition.
[9] J. Manson,et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. , 2007, Archives of internal medicine.
[10] D. Jacobs,et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. , 2007, The American journal of clinical nutrition.
[11] Philippe Amouyel,et al. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. , 2006, The Journal of nutrition.
[12] John Robbins,et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.
[13] R. Hayes,et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. , 2006, Journal of the National Cancer Institute.
[14] S. Yusuf,et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.
[15] Roberto Pastor-Barriuso,et al. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.
[16] Alain Favier,et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. , 2004, Archives of internal medicine.
[17] A. Folsom,et al. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? , 2004, The American journal of clinical nutrition.
[18] MahmoudZureik,et al. Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries , 2004 .
[19] P. Ducimetiere,et al. Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[20] J. Manson,et al. Vitamin C and risk of coronary heart disease in women. , 2003, Journal of the American College of Cardiology.
[21] J. Hsia,et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. , 2002, JAMA.
[22] W. W. Adams,et al. Antioxidants in Photosynthesis and Human Nutrition , 2002, Science.
[23] J. Manson,et al. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. , 2002, Archives of internal medicine.
[24] R. Collins,et al. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[25] Tw. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002, The Lancet.
[26] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[27] E. Bolson,et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.
[28] L. Kuller. A time to stop prescribing antioxidant vitamins to prevent and treat heart disease? , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[29] B. G. Brown,et al. Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[30] J. Dwyer,et al. Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis: The Los Angeles Atherosclerosis Study , 2001, Circulation.
[31] M. D. De Buyzere,et al. Serum Vitamin C Concentration Is Low in Peripheral Arterial Disease and Is Associated With Inflammation and Severity of Atherosclerosis , 2001, Circulation.
[32] S. Yusuf,et al. Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) , 2001, Circulation.
[33] T. Lakka,et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis , 2000, Journal of internal medicine.
[34] M. Boaz,et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.
[35] C. A. Johnson,et al. Blood pressure, LDL cholesterol, and intima-media thickness: a test of the "response to injury" hypothesis of atherosclerosis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[36] L. Labree,et al. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. , 2000, Atherosclerosis.
[37] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[38] Roberto Marchioli,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .
[39] J. Fleg,et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. , 1998, Circulation.
[40] R H Selzer,et al. Automated intima-media thickness: the Los Angeles Atherosclerosis Study. , 1998, Ultrasound in medicine & biology.
[41] R H Selzer,et al. The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.
[42] T. Cole,et al. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over , 1997, European Journal of Clinical Nutrition.
[43] J. Scott. Bioavailability of vitamin B12. , 1997, European journal of clinical nutrition.
[44] C. Bates. Bioavailability of vitamin C. , 1997, European journal of clinical nutrition.
[45] Paul Knekt,et al. Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.
[46] D Kromhout,et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.
[47] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[48] J. Gregory. Ascorbic acid bioavailability in foods and supplements. , 2009, Nutrition reviews.
[49] M. Gail,et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.
[50] P. Taylor,et al. The bioavailability to humans of ascorbic acid from oranges, orange juice and cooked broccoli is similar to that of synthetic ascorbic acid. , 1993, The Journal of nutrition.
[51] E. Rimm,et al. Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.
[52] J. Manson,et al. Dietary Antioxidants and Cardiovascular Disease , 1992, Annals of the New York Academy of Sciences.
[53] R. Hoffmann,et al. Ascorbic acid requirements for smokers: analysis of a population survey. , 1991, The American journal of clinical nutrition.
[54] R. Ziegler,et al. Ascorbic and dehydroascorbic acids measured in plasma preserved with dithiothreitol or metaphosphoric acid. , 1990, Clinical chemistry.
[55] D Feskanich,et al. Computerized collection and analysis of dietary intake information. , 1989, Computer methods and programs in biomedicine.
[56] S. Omaye,et al. An internal standard method for the unattended high-performance liquid chromatographic analysis of ascorbic acid in blood components. , 1987, Analytical biochemistry.
[57] J. Dwyer,et al. Statistical Models for the Social and Behavioral Sciences , 1983 .